SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹414 Cr | ₹343 Cr | ₹369 Cr | ₹327 Cr | ₹511 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹414 Cr |
Mar2023 | ₹343 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹327 Cr |
Mar2020 | ₹511 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹414 Cr | 20.70 | |
Mar2023 | ₹343 Cr | -7.09 | |
Mar2022 | ₹369 Cr | 12.82 | |
Mar2021 | ₹327 Cr | -35.98 | |
Mar2020 | ₹511 Cr | - |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹434,597.2 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹106,527.0 Cr | -2.8% | -0.7% | 52% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% |
-4% |
52.9% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses